
Episode 4: Enavate Sciences’ Sara Nayeem
BioVenture VoiCes with Chris Garabedian
00:00
Innovate Sciences structure and strategy
Sara describes Innovate as a Patient Square portfolio company investing $20–30M first checks into therapeutics.
Play episode from 50:23
Transcript


